Arcus Biosciences Statistics
Total Valuation
RCUS has a market cap or net worth of $3.64 billion. The enterprise value is $3.11 billion.
| Market Cap | 3.64B |
| Enterprise Value | 3.11B |
Important Dates
The last earnings date was Wednesday, August 5, 2026, after market close.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
RCUS has 127.33 million shares outstanding. The number of shares has increased by 22.85% in one year.
| Current Share Class | 127.33M |
| Shares Outstanding | 127.33M |
| Shares Change (YoY) | +22.85% |
| Shares Change (QoQ) | +0.56% |
| Owned by Insiders (%) | 3.60% |
| Owned by Institutions (%) | 69.97% |
| Float | 88.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 31.15 |
| Forward PS | 82.44 |
| PB Ratio | 7.83 |
| P/TBV Ratio | 7.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 26.56 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.82, with a Debt / Equity ratio of 0.51.
| Current Ratio | 3.82 |
| Quick Ratio | 3.75 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -44.18 |
Financial Efficiency
Return on equity (ROE) is -90.82% and return on invested capital (ROIC) is -43.99%.
| Return on Equity (ROE) | -90.82% |
| Return on Assets (ROA) | -30.39% |
| Return on Invested Capital (ROIC) | -43.99% |
| Return on Capital Employed (ROCE) | -66.94% |
| Weighted Average Cost of Capital (WACC) | 8.40% |
| Revenue Per Employee | $194,676 |
| Profits Per Employee | -$765,391 |
| Employee Count | 601 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +201.58% in the last 52 weeks. The beta is 0.81, so RCUS's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | +201.58% |
| 50-Day Moving Average | 27.26 |
| 200-Day Moving Average | 23.57 |
| Relative Strength Index (RSI) | 52.86 |
| Average Volume (20 Days) | 1,120,499 |
Short Selling Information
The latest short interest is 12.56 million, so 9.86% of the outstanding shares have been sold short.
| Short Interest | 12.56M |
| Short Previous Month | 13.27M |
| Short % of Shares Out | 9.86% |
| Short % of Float | 14.11% |
| Short Ratio (days to cover) | 8.15 |
Income Statement
In the last 12 months, RCUS had revenue of $117.00 million and -$460.00 million in losses. Loss per share was -$3.86.
| Revenue | 117.00M |
| Gross Profit | -380.00M |
| Operating Income | -486.00M |
| Pretax Income | -460.00M |
| Net Income | -460.00M |
| EBITDA | -476.00M |
| EBIT | -486.00M |
| Loss Per Share | -$3.86 |
Balance Sheet
The company has $702.00 million in cash and $238.00 million in debt, with a net cash position of $537.00 million or $4.22 per share.
| Cash & Cash Equivalents | 702.00M |
| Total Debt | 238.00M |
| Net Cash | 537.00M |
| Net Cash Per Share | $4.22 |
| Equity (Book Value) | 464.00M |
| Book Value Per Share | 3.65 |
| Working Capital | 558.00M |
Cash Flow
In the last 12 months, operating cash flow was -$474.00 million and capital expenditures -$1.00 million, giving a free cash flow of -$475.00 million.
| Operating Cash Flow | -474.00M |
| Capital Expenditures | -1.00M |
| Depreciation & Amortization | 10.00M |
| Net Borrowing | n/a |
| Free Cash Flow | -475.00M |
| FCF Per Share | -$3.73 |
Margins
| Gross Margin | n/a |
| Operating Margin | -415.38% |
| Pretax Margin | -393.16% |
| Profit Margin | n/a |
| EBITDA Margin | -406.84% |
| EBIT Margin | -415.38% |
| FCF Margin | n/a |
Dividends & Yields
RCUS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.85% |
| Shareholder Yield | -22.85% |
| Earnings Yield | -12.62% |
| FCF Yield | -13.03% |
Analyst Forecast
The average price target for RCUS is $38.00, which is 32.77% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $38.00 |
| Price Target Difference | 32.77% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | -9.67% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RCUS has an Altman Z-Score of -0.44. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.44 |
| Piotroski F-Score | n/a |